Clinical Trials for Transformed Non-Hodgkin Lymphoma

Find clinical trials for transformed non-hodgkin lymphoma. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

NCT ID: NCT05828589

This clinical trial is studying a new drug called BGB-21447, which is designed to help people with certain types of cancer affecting B-cells, such as non-Hodgkin lymphoma and chronic lymphocytic le...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Rozzano, , Italy +44 more

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

NCT ID: NCT05432635

This clinical trial is exploring a new treatment approach for patients with intermediate or high-grade B-cell non-Hodgkin lymphoma, which is a type of cancer affecting the lymphatic system. The stu...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

A Study of WZTL-002 CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

NCT ID: NCT06486051

This clinical trial is studying a new treatment called WZTL-002 CAR T-cell therapy for adults with certain types of large B-cell lymphoma, which is a type of cancer that affects the immune system. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Auckland, , New Zealand, Newtown, Wellington, New Zealand +1 more

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

NCT ID: NCT05890352

This clinical trial is exploring new ways to treat large B-cell lymphoma that has come back or did not respond to previous treatments. Researchers are studying how well a combination of four medica...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Ann Arbor, Michigan, United States +10 more

Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma

NCT ID: NCT04491370

This clinical trial is studying a new treatment approach for patients with certain types of B-cell lymphomas and Hodgkin lymphoma. Participants will first undergo a procedure called autologous stem...

Recruiting

Phase: PHASE1 Type: interventional Locations: Valhalla, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions